Home/Filings/4/0001013606-19-000029
4//SEC Filing

Thompson Matthew 4

Accession 0001013606-19-000029

CIK 0001013606other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:03 PM ET

Size

4.8 KB

Accession

0001013606-19-000029

Insider Transaction Report

Form 4
Period: 2019-01-31
Thompson Matthew
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-01-31+19,142542,319 total
Footnotes (1)
  • [F1]100% of the time-based restricted stock unit award shall vest on January 31, 2020 and shall settle in shares of common stock.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001740988

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:03 PM ET
Size
4.8 KB